The largest database of trusted experimental protocols

Picogreen fluorescence assay

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PicoGreen fluorescence assay is a highly sensitive and specific method for quantifying double-stranded DNA (dsDNA) in solution. It utilizes a fluorescent dye that binds to dsDNA, allowing for the accurate measurement of DNA concentrations in a variety of sample types.

Automatically generated - may contain errors

19 protocols using picogreen fluorescence assay

1

Automated Microbiome DNA Extraction and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The University of California Microbiome Core performed nucleic acid extractions using previously published protocols (D’Amato et al. 2020 (link)). Briefly, extractions and purifications were performed using the MagMAX Microbiome Ultra Nucleic Acid Isolation Kit (Thermo Fisher Scientific, USA) and automated on KingFisher Flex robots (Thermo Fisher Scientific, USA). Blank controls and mock communities (Zymo Research Corporation, USA) were carried through all downstream processing steps. Input DNA was quantified using a PicoGreen fluorescence assay (Thermo Fisher Scientific, USA) and metagenomic libraries were prepared with Illumina DNA Prep kits (Illumina Incorporated, USA) following the manufacturer’s instructions and automated on epMotion automated liquid handlers (Eppendorf, Germany). Sequencing was performed on the Illumina NovaSeq 6000 sequencing platform with paired-end 150 base pair cycles at the Institute for Genomic Medicine (IGM) at the University of California San Diego.
+ Open protocol
+ Expand
2

Circulating Tumor DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 ml of whole blood was collected by ethylenediamine tetraacetic acid (EDTA) blood collection tubes then transported at ambient temperature to Nanjing Shihe Jiyin Biotech Inc. (Nanjing, China) no more than 72 h. Blood was centrifuged at 1800 × g for 10 minutes at 4°C to remove blood cells. Then, the supernatant was centrifuged at 16000 × g for 10 minutes at 4°C to remove any remaining cells. Circulating tumor DNA was extracted from 2 ml plasma, by digestion in 100 μl proteinase K buffer for 10 min at 37°C followed by purification with the NucleoSpin Plasma XS kit with modified protocols. The purified ctDNA is quantified by a Picogreen fluorescence assay using the provided lambda DNA standards (Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
3

Targeted Sequencing of Retinal Disease Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
We sequenced 300 genes that were associated with retinal disease for each patient using a capture panel that our group previously developed (Supplementary Table S1). The panel also includes the frequent pathogenic intronic variant c.2992+1655A>G that has been established to create a donor splice site within intron 26 of CEP290, causing the inclusion of a cryptic exon and a premature stop codon [17 (link)].
For capture sequencing, we generated paired-end libraries, according to the manufacturer’s protocol. We began by shearing 1 ug of genomic DNA into 300–500 base pair (bp) fragments and by adding an adenosine base to the 3′ end using the Klenow exonuclease. Y-shaped index adaptors were ligated to the fragments and 8–10 cycles of PCR amplification were performed for each sample. The DNA libraries were quantified using the PicoGreen fluorescence assay (ThermoFisher Scientific) and 50 ng of the generated libraries were used for each capture reaction. NimbleGen SeqCap EZ (Roche, Pleasanton, CA, USA) Hybridization and Wash kits were used for washing and recovering captured DNA. The captured DNA was quantified and was sent for sequencing using an Illumina HiSeq 2000 machine, following the manufacturer’s protocol. Illumina sequencing was performed at Baylor College of Medicine’s Human Genome Sequencing Center (Houston, TX, USA).
+ Open protocol
+ Expand
4

NGS-based DNA extraction and sequencing of FFPE samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
FFPE samples containing at least 20% tumor cells [as determined from the examination of hematoxylin and eosin (H&E)-stained sections] were deparaffinized and genomic DNA (gDNA) was extracted using QIAamp DNA FFPE Tissue Kit (Qiagen, Hilden, Germany) in accordance with manufacturer’s instructions, followed by quantification using PicoGreen fluorescence assay (Invitrogen). The gDNA from white blood cell (WBC) samples was extracted using QIAamp DNA Blood Mini Kit (Qiagen) as described by the manufacturer.
All sequencing processes were accomplished in 3DMed Medical Laboratory Co., Ltd (Shanghai) (22 (link)). The details of NGS method are described in manuscript communicated for publication (Paper #NCOMMS-18-38299C). Illumina NextSeq 500 was used to sequence samples with the IDT xGen hybridization buffer. To evaluate the quality of the sequencing data, we used FastQC software (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/). BWA-MEM was used to map the sequence data to the human genome (hg19) reference. The results were sorted, and duplicate reads were removed with Picard (http://broadinstitute.github.io/picard/) (23 (link),24 (link)). In general, the mean sequencing depth of FFPE samples was 394× and that of matched blood samples was 431×.
+ Open protocol
+ Expand
5

Genome Sequencing of L. Lactis Mutant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA of the mutant was purified using DNeasy Blood & Tissue Kit (Qiagen) and the quality was checked by DNA electrophoresis and NanoDrop 1000 (Thermo Fisher Scientific) analysis. Genome sequencing was performed by Macrogen. The procedure described briefly: 2 μg genomic DNA was randomly sheared using a nebulizer (Illumina) and the ends were repaired using polynucleotide kinase and Klenow enzyme. The 5′-ends of the DNA fragments were phosphorylated and a single adenine base was added to the 3′-ends using Klenow exo+ (Illumina). Following ligation of a pair of Illumina adaptors to the repaired ends, the DNA was amplified in 10 cycles, using adaptor primers (Illumina), and fragments of around 150 bp were isolated using agarose gel electrophoresis. Sequencing libraries were quantified with a 2100 BioAnalyzer DNA 1000 chip (Agilent) as well as the Picogreen fluorescence assay (Invitrogen). Cluster generations were performed on an Illumina cluster station using 11 pmol of sequencing libraries. A total of 38 cycles of sequencing were carried out using the Illumina Genome Analyzer IIx system according to the manufacturer’s specifications. CLC Genomics Workbench was used for mapping the reads, SNP and DIP detection and identification of genomic rearrangement using the published genome sequence of L. Lactis MG136323 (link)24 (link) as the reference.
+ Open protocol
+ Expand
6

Whole Genome Sequencing of Frozen Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from the frozen tissues using a Puregene DNA extraction kit (Qiagen) and quantified using a PicoGreen fluorescence assay (Qubit; Invitrogen). To conduct whole genome sequencing, 2 μg of DNA were required for each sample. After electrophoresis, DNA fragments of the desired length were gel purified. Adapter ligation and DNA cluster preparation were performed and subjected to Illumina Hiseq2000 sequencing. Two paired-end libraries with an insert size of 500 bp were prepared for all samples, after which four lanes from each library were subjected to whole genome sequencing. Raw image files were processed by Illumina Pipeline for base calling with default parameters, and the sequences of each individual were generated as 90-bp paired-end reads. Raw sequence data was mapped to the reference human genome (hg19) using Bowtie 2. The total mapping rate was >90%, and the average coverage was about 30×. Unmapped reads were then used to conduct genomic fusion detection with FusionMap [16 (link)].
+ Open protocol
+ Expand
7

Cancer Gene Panel Sequencing from FFPE

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin in formalin-fixed paraffin-embedded (FFPE) sections were removed by xylenes. Genomic DNA was then extracted with QIAamp DNA FFPE Tissue Kit (Qiagen) and quantified by PicoGreen fluorescence assay (Invitrogen). gDNAs were constructed into the libraries with KAPA Hyper Prep Kit (Kapa Biosystems).
For targeted capture, indexed libraries were subjected to probe-based hybridization with a customized NGS panel targeting 733 cancer-related genes, where the probe baits were individually synthesized with 5’-biotinylated 120 bp DNA oligonucleotides (IDT) and repetitive elements were filtered out from intronic baits according to the annotation by UCSC Genome RepeatMasker. The xGen® Hybridization and Wash Kit (IDT) was employed for hybridization enrichment. The captured DNAs were then amplified by PCR, whose final DNA concentrations were determined by Qubit and the DNA sizes were analyzed by Caliper. Libraries were adjusted to 1.05 nM and sequenced in NGS platform illumina Nextseq 500 with Illumina version 4 sequencing kits according to the manufacturer’s instructions. In all, 733 targeted cancer-related genes were listed in Supplementary Table S19.
+ Open protocol
+ Expand
8

Quantitative 3C Assay for hTERT Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
3C-qPCR assays were performed as previously described69 (link) with slight modifications. Briefly, the assays were performed on PC3 cells overexpressed with HOXC5 or control GFP. 1 × 107 nuclei were cross-linked with 1% formaldehyde, digested using DpnII and ligated as described69 (link). DNA was then reverse cross-linked and purified by extraction with phenol/chloroform, followed by precipitation with ethanol. The DNA concentration of the 3 C libraries was determined using Picogreen fluorescence assay (Invitrogen). 3C-qPCR reactions were performed by the Sybr-Greener Kit (Invitrogen), and the chromatin interactions were normalized by loading control. On the basis of the 4C-seq data, we selected a region in the hTERT coding region with background levels of interaction, with a similar genomic distance from the hTERT bait region as the experimental interaction, to serve as a control interaction. The primers used for 3c-qPCR are listed in Supplementary Table 2.
+ Open protocol
+ Expand
9

Tumor Cell Enrichment for DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sections were deparaffinized, rinsed and stained in 0.1% toluidine blue for 30 s, washed, air dried, and stored before microdissection. This microdissection was made manually using a scalpel blade under microscopic control to remove a majority of the non-neoplastic tissue, such as immune cells or necrosis, in order to enrich the samples to at least 70% of tumor cells. The pathologist (LL) confirmed the accuracy of this procedure before the collection of the enriched tumor samples. DNA was extracted using the Promega Maxwell 16 FFPE Plus LEV DNA Purification Kit (Promega, Madison, WI, USA) following manufacturer’s instructions. DNA quantification was performed using standardized PicoGreen fluorescence assay (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
10

DNA Extraction from FFPE Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin in Formalin Fixed Paraffin Embedded (FFPE) sections and cores was removed by xylenes, followed by ethanol washing. Tissues were digested by proteinase K at 56 °C overnight and incubated at 90 °C for 5 min to reverse DNA crosslink. Genomic DNA was then extracted with QIAamp DNA FFPE Tissue Kit (Qiagen) and quantified by PicoGreen fluorescence assay (Invitrogen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!